In today’s recent session, 1.21 million shares of the Boston Scientific Corp. (NYSE:BSX) have been traded, and its beta is 0.80. Most recently the company’s share price was $82.15, and it changed around -$0.37 or -0.45% from the last close, which brings the market valuation of the company to $120.98B. BSX at last check was trading at a discount to its 52-week high of $84.11, offering almost -2.39% off that amount. The share price’s 52-week low was $48.35, which indicates that the recent value has risen by an impressive 41.14% since then. We note from Boston Scientific Corp.’s average daily trading volume that its 10-day average is 4.84 million shares, with the 3-month average coming to 5.56 million.
Boston Scientific Corp. stock received a consensus recommendation rating of Overweight, based on a mean score of 1.46. If we narrow it down even further, the data shows that 0 out of 24 analysts rate the stock as a Sell; another 10 rate it as Overweight. Among the rest, 6 recommended BSX as a Hold, whereas 8 deemed it a Buy, and 0 rated it as Underweight. Boston Scientific Corp. is expected to report earnings per share of 0.59 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Boston Scientific Corp. (NYSE:BSX) trade information
Instantly BSX has been showing red trend so far today with a performance of -0.45% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 84.11 on recent trading dayincreased the stock’s daily price by 2.33%. The company’s shares are currently up 42.10% year-to-date, but still down -0.95% over the last five days. On the other hand, Boston Scientific Corp. (NYSE:BSX) is 4.41% up in the 30-day period. We can see from the shorts that 11.02 million shares have been sold at a short interest cover period of 2.24 day(s).
The consensus price target as assigned by Wall Street analysts is $77, which translates to bulls needing to decrease their stock price by -6.69% from its current value. Analyst projections state that BSX is forecast to be at a low of $48 and a high of $118.
Boston Scientific Corp. (BSX) estimates and forecasts
Boston Scientific Corp. share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 21.18 percent over the past six months and at a 17.07% annual growth rate that is well above the industry average of 13.50%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 18.00% in revenue this quarter, and will report an increase of 16.40% in the next quarter. The year-over-year growth rate is expected to be 14.30%, up from the previous year.
Consensus estimates provided by 24 financial analysts predict the company will bring in an average of 4.04B in revenue for the current quarter. 24 analysts expect Boston Scientific Corp. to make 4.27B in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 3.53B and 3.73B respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 14.40%. Forecasts for the next quarter put sales growth at 14.50%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -2.05%. Boston Scientific Corp. earnings are expected to increase by 17.45% in 2024, but the outlook is positive 12.84% per year for the next five years.
BSX Dividends
Boston Scientific Corp.’s next quarterly earnings report is expected to be released on 2024-Oct-24.
Boston Scientific Corp. (NYSE:BSX)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.18% of Boston Scientific Corp. shares, and 92.86% of them are in the hands of institutional investors. The stock currently has a share float of 93.03%. Boston Scientific Corp. stock is held by 1912.0 institutions, with FMR LLC being the largest institutional investor. By 2024-06-30, it held 9.6337% of the shares, which is about 141.46 million shares worth $10.89 billion.
VANGUARD GROUP INC, with 8.8444% or 129.87 million shares worth $10.0 billion as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and Vanguard 500 Index Fund were the top two Mutual Funds as of Jun 30, 2024. The former held 46.45 shares worth $3.83 billion, making up 3.15% of all outstanding shares. On the other hand, Vanguard 500 Index Fund held roughly 37.73 shares worth around $3.11 billion, which represents about 2.56% of the total shares outstanding.
